News & Publications

2007 Annual Meeting Media Advisory

The American Society for Bone and Mineral Research

The ASBMR 29th Annual Meeting offers an exceptional scientific program, presenting innovative research, technology, and new clinical treatments in bone diseases and disorders of mineral metabolism.

This year’s Annual Meeting, held in Honolulu, Hawaii, September 16-19th, 2007, brings together more than 5,000 researchers and clinicians from around the world.

The meeting includes lectures and symposia plus 1500 poster presentations and over 300 oral presentations including a new oral poster session for the highest rated posters.

Highlights of the meeting will include:

• Invited Speaker Sessions:
• Plenary Lectures by Tatsuo Suda, D.D.S., Ph.D on Contributions to Osteoclast Biology and Michael Berridge, FRS on Calcium Signaling in Health and Disease
• Joint ECTS/ASBMR Session on Osteonecrosis of the Jaw
• A controversial debate on Excessive Suppression of Bone Remodeling by Antiresorptive Agents - Fact or Fiction?
• Plenary Symposia on How Can We Find New Drugs for Bone in the 21st Century? , Emerging Technologies in Functional Bone Imaging and Bone Quality: Age-Related Changes in Collagen and Mineral
• Overview of the ASBMR 29 th Annual Meeting by Lawrence Raisz, M.D.
• Concurrent Oral Session 10. Osteoporosis Treatment (Clinical) I: Bisphosphonates - Monday, September 17, 2007, 2:30 pm - 4:00 pm
• Efficacy and Safety of Zoledronic Acid 5 mg in Preventing Fractures In Men and Women With Prevalent Hip Fracture: The HORIZON-Recurrent Fracture Trial (Presentation #1055)
• Risk Factors for Serious Adverse Events (SEAs) of Atrial Fibrillation in the HORIZON-PFT Train of Zoledronic Acid (Presentation #1056)
• Concurrent Oral Session 33. Osteoporosis Treatment (Clinical) IV:
  Anti-resorptives - Wednesday, September 19, 2007, 10:00 am - 11:30 am
• Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo- and Active-Controlled Clinical Trial (Presentation #1206)

For registration information, please contact Greg Akroyd at gakroyd@asbmr.org.

###

The ASBMR Annual Meeting is the pre-eminent scientific meeting on bone and mineral metabolism. More than 5,000 participants are expecte d to attend the September 16-19 meeting, where nearly 1,800 scientific abstracts are presented. The ASBMR is the premier professional, scientific an d me dical society established to promote excellence in bone and mineral research and to facilitate the translation of that research into clinical practice. The ASBMR has a membership of nearly 4,000 physicians, basic research scientists, and clinical investigators. To learn more about the Society and the fiel d of bone and mineral research, visit the ASBMR website at www.asbmr.org.

Return to News Releases Index